2006 Annual Meeting | Controversies in Critical Care of Brain Hemorrhage

Date Monday 04/03/06

Time 06:45 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Breakfast Seminar

Director(s) Paul M. Vespa, MD, FAAN

Topic(s)

Learning Objectives Upon Completion:
Participants should be able to plan and execute emergency and critical care medical treatments for intracerebral and subarachnoid hemorrhage; have an up-to-date knowledge of ongoing trial results; and have an appreciation for and be able to advise patients/families on the optimal treatment strategies for brain hemorrhage.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Resident

Event Timeline
06:45 AM - 08:30 AM		Controversies in Critical Care of Brain Hemorrhage Chad M. Miller, MD, Claude Hemphill III, MD, FAAN, Stephan A. Mayer, MD, Paul M. Vespa, MD, FAAN
06:45 AM - 08:30 AM		Breakfast

Faculty Disclosures
Claude Hemphill III, MD, FAAN	Dr. Hemphill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Hemphill has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Hemphill has received research support from NIH/NINDS.
Paul M. Vespa, MD, FAAN	Dr. Vespa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ceribell. Dr. Vespa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ceribell. Dr. Vespa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ceribell. Dr. Vespa has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. The institution of Dr. Vespa has received research support from NIH. Dr. Vespa has received intellectual property interests from a discovery or technology relating to health care.
Stephan A. Mayer, MD	Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phagenesis. Dr. Mayer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astra Zeneca. Dr. Mayer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Mayer has stock in Neuroptics. Dr. Mayer has received publishing royalties from a publication relating to health care.
Chad M. Miller, MD	No disclosure on file

��ɫ��

��ɫ��